about
Augmentation of mechanical properties in osteoporotic vertebral bones--a biomechanical investigation of vertebroplasty efficacy with different bone cementsRadiometrical, hormonal and biological correlates of skeletal growth in the female rat from birth to senescenceReduction of falls and fractures after permanent pacemaker implantation in elderly patients with sinus node dysfunction.Graded doses of recombinant interleukin-1beta induce generalized osteopenia in rats without altering skeletal growth and joint integrity.A review of the cost effectiveness of bisphosphonates in the treatment of post-menopausal osteoporosis in Switzerland.An educational review of cartilage repair: precepts & practice--myths & misconceptions--progress & prospects.Microstructural parameters of bone evaluated using HR-pQCT correlate with the DXA-derived cortical index and the trabecular bone score in a cohort of randomly selected premenopausal womenMedical treatment of vertebral osteoporosisThe effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT).Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 yearsThe effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension studyThe prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation.Bone mineral density at distal tibia using dual-energy X-ray absorptiometry in normal women and in patients with vertebral osteoporosis or primary hyperparathyroidism.Dual-energy X-ray absorptiometry for measuring total bone mineral content in the rat: study of accuracy and precision.Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density.The future of osteoporosis treatment - a research update.How best to preserve and reveal the structural intricacies of cartilaginous tissue.Prediction of hip fracture risk by quantitative ultrasound in more than 7000 Swiss women > or =70 years of age: comparison of three technologically different bone ultrasound devices in the SEMOF study.Comparison of three bone ultrasounds for the discrimination of subjects with and without osteoporotic fractures among 7562 elderly women.10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension.Quality controls for two heel bone ultrasounds used in the Swiss Evaluation of the Methods of Measurement of Osteoporotic Fracture Risk Study.Novel organ-slice culturing system to simulate meniscal repair: Proof of concept using a synovium-based pool of meniscoprogenitor cells.Compressive strength of interbody cages in the lumbar spine: the effect of cage shape, posterior instrumentation and bone density.Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women.A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX.A model of osteoporosis impact in Switzerland 2000-2020.The Initial Slope of the Variogram, Foundation of the Trabecular Bone Score, Is Not or Is Poorly Associated With Vertebral Strength.Long-bone fractures in persons with spinal cord injury.Eccentric exercise in coronary patients: central hemodynamic and metabolic responses.No evidence of osteopenia 5 to 8 years after ileal orthotopic bladder substitution.[Osteoporosis -- a global challenge?].Fracture hospitalizations between years 2000 and 2007 in Switzerland: a trend analysis.Changes in bone mineral density over 18 months following kidney transplantation: the respective roles of prednisone and parathyroid hormone.Which factors account for renal stone formation in cystic fibrosis?Comparative trends in hospitalizations for osteoporotic fractures and other frequent diseases between 2000 and 2008.1,25-(OH)2-16ene-23yne-D3 reduces secondary hyperparathyroidism in uremic rats with little calcemic effect.Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a three-year study.Prevention of bone loss in paraplegics over 2 years with alendronate.Denosumab significantly increases DXA BMD at both trabecular and cortical sites: results from the FREEDOM study.Cortical and trabecular bone mineral density in transsexuals after long-term cross-sex hormonal treatment: a cross-sectional study.
P50
Q24289479-5DEB44A5-8CE3-4D6F-9C0B-1A0240E0495FQ28566161-F5675256-3172-4C30-BDC5-19EC6B0BBEF8Q33167758-71546F72-DBD9-47DD-98E8-BFA161C75FCFQ33223126-615D31BE-A632-4022-B558-95EFCD247265Q34016943-CC3190C5-2489-4CD0-87F1-79661E056E1CQ34455298-0304E757-A8C3-492A-B074-0BCA6FEF63A0Q35097644-D84F59AF-A6D3-46BC-9AE6-5E625537EE70Q35299212-378384B5-8367-4CF3-B6FA-61E960534D0AQ36190027-C9642E48-D52F-4EE4-8412-637B946452FBQ36309349-79B15AF8-AAF2-4F1A-84A7-068598640D7DQ36309353-EB59D7AA-C865-429B-9DF0-DD633B0C24AEQ36570780-D865AD52-98F3-41E1-B36E-BEA3DC756CB0Q36717594-AC719471-F2B1-4416-B5CD-9683F566A225Q36725796-40CED0F8-A4D7-45CD-A1A9-AE6511B34C39Q37401870-AF8A56B2-0FE5-4C3B-B59B-1633BA375140Q38027805-982EDCE3-AC77-4530-8D3E-0D5D2618B6A7Q38244833-96DE1335-55B7-4E77-A53C-24CD9A3609FCQ38508968-8907B19E-78D5-4E1B-B897-D96CCBF17D52Q38519963-0FD987F7-75AF-4D6D-AEC7-05F3F0D70820Q38762939-59824351-310E-4AA9-AAA1-E5353694BF81Q39148383-4E6D2DBB-3321-486E-B51D-7173E30EFA60Q39177838-DD631128-3034-4DA2-9068-EF86E3090425Q39406083-9C5D9AC7-3AD4-41E4-8BA3-480FC68443E4Q40031277-504053C5-ECBA-462B-A55C-6EBB66A3D8C1Q40396538-988B56A6-E3D9-462B-8FE0-2395D92A70C3Q40471619-8D64F3EF-11DD-4BE1-B698-2A60E8914CCAQ40668913-3FD20689-2463-4C05-8CF4-C92199761440Q40926280-84638771-E9E3-46B8-A5AB-8B9FF3210A33Q42163959-73F45532-CF44-45EB-B0C0-0848CC13849AQ43420638-7C1D8F0D-30B5-4949-9A01-D21681C8CEF2Q43863395-48CA63C0-7628-4432-B6C3-7041025CF539Q43950222-009D0E5F-C4DB-444E-93F0-862BD47FFB59Q44053841-0CCC87CF-31F3-470A-A099-7FFEE19275F1Q44373191-DC93656C-15A7-4CB7-85BC-5C97FCF91EE9Q44584358-54011F5B-2B55-43FA-BE4F-6D5FF86C5718Q44674788-CD34DE47-4770-46D2-AF57-57FA2E22BD22Q44688610-77289B60-A5DC-4387-96EB-7F52C8F45587Q44920759-C4CC5B94-98F5-4593-9F6C-45B0A66D62B0Q45106940-F372753E-4655-49EE-8F94-06BEAF56D6A8Q45122719-8377490E-C9D1-44CE-A7C9-44DD18D14253
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kurt Lippuner
@ast
Kurt Lippuner
@en
Kurt Lippuner
@es
Kurt Lippuner
@nl
Kurt Lippuner
@sl
type
label
Kurt Lippuner
@ast
Kurt Lippuner
@en
Kurt Lippuner
@es
Kurt Lippuner
@nl
Kurt Lippuner
@sl
prefLabel
Kurt Lippuner
@ast
Kurt Lippuner
@en
Kurt Lippuner
@es
Kurt Lippuner
@nl
Kurt Lippuner
@sl
P106
P108
P21
P31
P496
0000-0002-7195-3779